59 results
8-K
EX-3.2
MYMD
MyMD Pharmaceuticals Inc
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
Nominating and Governance Committee, which approval shall not be unreasonably withheld. If the Holders of the Preferred Shares fail to elect
8-K
EX-3.2
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
by the Company’s Nominating and Governance Committee, which approval shall not be unreasonably withheld. If the Holders of the Preferred Shares fail to elect
8-K
EX-3.1
MYMD
MyMD Pharmaceuticals Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
) director of the Company one time, provided that such election shall be approved by the Company’s Nominating and Governance Committee, which approval
8-K
EX-3.2
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
corporate governance guideline or committee charter of the Corporation and (3) such other information that could be material to a reasonable stockholder’s
8-K
EX-10.4
qqx32uoxl3m yy
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-10.6
zt92e
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-10.3
77j3p6tpgv b2t
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-10.5
4jbm8ysa5yo 2w7
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
2iqj9p7fllrsg1q3ise
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
S-4/A
vivg 8ahk5p380j
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
S-4
58t0wvhd vaiy
15 Jan 21
Registration of securities issued in business combination transactions
5:24pm